Executive Insights: Drugs & Money in a Time of Change

Join us for discussions and presentations on how to succeed in an unpredictable market.

This forum is by-invitation and will provide insights from growing companies, investors, capital and strategic advisors on how to navigate an increasingly complex global market and bring new treatments to the clinic and the market in Sweden, the US and around the world. A day of knowledge, creativity, new ideas and networking! 

Sign up through the button and scroll down to see event details and speakers. The event will be in Swedish with some parts in English.

See you on the 10th of April!

Cytel, DNB//Back Bay, Flerie and Linc

Event details

When? 10th of April, 09:30-16:15.

Where? World Trade Center, Klarabergsviadukten 70, Stockholm.

How? Register through sign up button in this invitation.

Event schedule

09:30

Coffee & registration

10:00

Welcoming remarks

10:10

Keynote: This is at stake

Katrine Kielos
Financial journalist & bestselling author
11:00

Networking break

11:15

Partnering session: Drugs, Deals and Decisions

Moderator: Karl Tobieson (Linc)

Read more
Mark Quick
Partner, Flerie
Kristen Albright, PharmD
CEO, Prokarium
Stephan Gauldie, PhD
Partner & Managing Director, Back Bay Life Science Advisors
Katarina Emanuelsson
Director Transactions, Business Development & Licensing, AstraZeneca
12:40

Lunch

13:50

Keynote: Everyone Has Misunderstood AI

Ashkan Fardost
Global speaker, entrepreneur & academic
14:40

Networking break

15:00

Lessons learned: Political and cultural challenges in expanding outside the Nordics

Moderator: Karl Tobieson (Linc)

Read more
Nikolaj Sørensen
CEO & President, Orexo AB
Börje Haraldsson
CEO, Oncorena AB
15:45

Drugs, deals and decisions – the balancing act of high innovation and big decisions

Moderator: Anna Törner (Cytel)

Read more
Johan Luthman
EVP & Head R&D, Lundbeck
16:15

Wine reception

Confirmed speakers

Ashkan Fardost
Global speaker, entrepreneur & academic

Read more

Katrine Kielos
Financial journalist & bestselling author

Read more

Johan Luthman
EVP & Head R&D, Lundbeck

Read more

Kristen Albright, PharmD
CEO, Prokarium

Read more

Nikolaj Sørensen
CEO & President, Orexo AB

Read more

Katarina Emanuelsson
Director Transactions, Business Development & Licensing, AstraZeneca

Read more

Mark Quick
Partner, Flerie

Read more

Stephan Gauldie, PhD
Partner & Managing Director, Back Bay Life Science Advisors

Read more

Börje Haraldsson
CEO, Oncorena AB

Read more